16th Annual NATA Symposium

16th Annual NATA Symposium, Prague 2015The 16th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will take place at the Prague Congress Centre in Prague, Czech Republic, on April 16-17, 2015.

The annual NATA symposium will provide a unique opportunity for stimulating and constructive exchanges across different specialities involved in patient blood management.

The final scientific programme is available, and 101 abstracts have been accepted for presentation.

The results of major, recently published or completed trials will be presented and discussed:

  • The Age of Blood Evaluation (ABLE) Randomised Controlled Trial
  • The Transfusion Requirements in Septic Shock (TRISS) Trial
  • Long-Term Mortality in the Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
  • Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: FIB-PPH Study
  • Liberal or Restrictive Transfusion after Cardiac Surgery: TITRe2 Study


The second announcement can be downloaded in PDF format.

More information on the Annual NATA Symposium

Follow NATA on LinkedIn and Twitter

Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter

News from the Industry: White Paper – Red Cell Salvage: Current Status

Intraoperative Red Cell Salvage (RCS) was introduced in the early 1980s and rapidly gained clinical acceptance. Early RCS was done without cell washing, but washed RCS became the standard of care in cardiac surgery and other procedures.

RCS gained popularity because it did not carry the risk of transfusion-transmitted diseases, notably HIV and hepatitis B and C, and decreased demand for allogeneic blood. While both of these benefits are still true today, the increased safety profile of allogeneic transfusion as well as the presence of stable blood inventories have diminished their importance.

Nevertheless, strong clinical and economic reasons remain to use RCS. This white paper addresses these issues.
Read more on this

News

Anaesthesia Supplement on ‘Transfusion, Thrombosis and Management of Bleeding’

Anaesthesia, the journal of the Association of Anaesthetists of Great Britain & Ireland, announces the publication of a special open-access supplement on Transfusion, Thrombosis and Management of Bleeding, to coincide with the UK launch of Patient Blood Management in the NHS.

A collaboration between anaesthetists, haematologists, surgeons and others, this supplement pulls together state-of-the-art research and recommendations into a comprehensive guide. World-renowned specialists have contributed a series of detailed reviews and debates.
Read more on this

From the Literature

Mar 31, 2015

Published: Mar 2015

Carson JL, Sieber F, Cook DR, et al.

Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial.
Lancet 2015;385:1183-1189.

#

NATA REVIEW:
Carson and colleagues report the long-term results of the FOCUS trial published in 2011. In FOCUS, 2016 elderly...
REVIEW by:
J.-F. Hardy

Published: Mar 2015

Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency.
Eur Heart J 2015;36:657-668.

#

NATA REVIEW:
The authors studied the benefits and safety of long-term intravenous iron therapy in patients with heart failure...
REVIEW by:
L. T. Goodnough

Published: Mar 2015

Murphy GJ, Pike K, Rogers CA, et al.

Liberal or restrictive transfusion after cardiac surgery.
N Engl J Med 2015;372:997-1008.

#

NATA REVIEW:
Murphy et al. conducted a very large (2003 patients) randomised trial comparing a liberal (threshold...
REVIEW by:
J.-F. Hardy

Published: Feb 2015

Reed GW, Kumar A, Guo J, et al.

Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify Pre-Op TIMI 45 – a pilot study.
Clin Cardiol 2015;38:92-98.

#

NATA REVIEW:
The authors performed a proof-of-principle pilot study indicating that point-of-care platelet function testing...
REVIEW by:
S. Kozek-Langenecker

Published: Jan 2015

Godier A, Taylor G, Gaussem P

Inefficacy of platelet transfusion to reverse ticagrelor.
N Engl J Med 2015;372:196-197.

#

NATA REVIEW:
Godier and colleagues describe a patient on dual antiplatelet therapy with ticagrelor and aspirin due to two...
REVIEW by:
P. Johansson

Published: Jan 2015

Clifford L, Jia Q, Yadav H, et al.

Characterizing the epidemiology of perioperative transfusion-associated circulatory overload.
Anesthesiology 2015;122:21-28.

#

NATA REVIEW:
The paper by Clifford et al. reports on the results of a very interesting retrospective study evaluating...
REVIEW by:
G. Inghilleri